OrganiGram (TSE:OGI) Receives “Neutral” Rating from CIBC

OrganiGram (TSE:OGI)‘s stock had its “neutral” rating reissued by equities researchers at CIBC in a research note issued on Friday, Stock Target Advisor reports.

Several other research firms have also issued reports on OGI. Raymond James reiterated an “outperform” rating and issued a C$5.00 target price on shares of OrganiGram in a research note on Wednesday, September 15th. Atb Cap Markets reissued a “sector perform” rating on shares of OrganiGram in a report on Friday, July 23rd. ATB Capital boosted their price target on shares of OrganiGram from C$3.75 to C$4.25 and gave the stock a “na” rating in a report on Wednesday, July 14th. Finally, Jefferies Financial Group upped their price objective on shares of OrganiGram from C$3.57 to C$3.83 in a report on Friday, September 3rd. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, OrganiGram currently has an average rating of “Hold” and an average price target of C$3.90.

Shares of OGI stock opened at C$3.05 on Friday. The firm has a market capitalization of C$911.29 million and a PE ratio of -4.89. The firm has a fifty day simple moving average of C$3.22 and a two-hundred day simple moving average of C$3.53. The company has a current ratio of 13.70, a quick ratio of 10.99 and a debt-to-equity ratio of 1.23. OrganiGram has a 12 month low of C$1.35 and a 12 month high of C$8.00.

OrganiGram (TSE:OGI) last posted its earnings results on Tuesday, July 13th. The company reported C($0.03) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of C($0.04) by C$0.01. The firm had revenue of C$20.32 million during the quarter, compared to the consensus estimate of C$17.41 million. On average, equities analysts predict that OrganiGram will post -0.11 earnings per share for the current fiscal year.

OrganiGram Company Profile

Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co, ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market.

Featured Story: What are momentum indicators and what do they show?

Stock Target Advisor logo

Analyst Recommendations for OrganiGram (TSE:OGI)

Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with's FREE daily email newsletter.